BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 11570567)

  • 1. Chemotherapeutic approaches to protozoa: Giardia, Trichomonas and Entamoeba--current level of knowledge and outlook.
    Harder A; Greif G; Haberkorn A
    Parasitol Res; 2001 Sep; 87(9):785-6. PubMed ID: 11570567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Chemotherapeutic approaches to protozoa: Giardia, Trichomonas and Entamoeba-current level of knowledge and outlook".
    Harder A
    Parasitol Res; 2002 Jun; 88(6):591. PubMed ID: 12152617
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiprotozoan activity of nitroimidazoles.
    De Carneri I
    Arzneimittelforschung; 1969 Mar; 19(3):382-6. PubMed ID: 4889732
    [No Abstract]   [Full Text] [Related]  

  • 4. Giardia, Entamoeba, and Trichomonas enzymes activate metronidazole (nitroreductases) and inactivate metronidazole (nitroimidazole reductases).
    Pal D; Banerjee S; Cui J; Schwartz A; Ghosh SK; Samuelson J
    Antimicrob Agents Chemother; 2009 Feb; 53(2):458-64. PubMed ID: 19015349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [CHARACTERISTICS OF PARASITIC PROTOZOA METABOLISM AND POSSIBILITIES OF ANTIPROTOZOA DRUG DEVELOPMENT (REVIEW)].
    Larina S; Sakharova T; Chebyshev N; Berechikidze I; Derkacheva N
    Georgian Med News; 2018 Jun; (279):171-175. PubMed ID: 30035741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of new 5-nitroimidazoles against metronidazole-susceptible and -resistant Giardia, Trichomonas, and Entamoeba spp.
    Upcroft JA; Campbell RW; Benakli K; Upcroft P; Vanelle P
    Antimicrob Agents Chemother; 1999 Jan; 43(1):73-6. PubMed ID: 9869568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug susceptibility testing of anaerobic protozoa.
    Upcroft JA; Upcroft P
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1810-4. PubMed ID: 11353630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New mechanisms of drug resistance in parasitic protozoa.
    Borst P; Ouellette M
    Annu Rev Microbiol; 1995; 49():427-60. PubMed ID: 8561467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current therapeutics, their problems, and sulfur-containing-amino-acid metabolism as a novel target against infections by "amitochondriate" protozoan parasites.
    Ali V; Nozaki T
    Clin Microbiol Rev; 2007 Jan; 20(1):164-87. PubMed ID: 17223627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug targets and mechanisms of resistance in the anaerobic protozoa.
    Upcroft P; Upcroft JA
    Clin Microbiol Rev; 2001 Jan; 14(1):150-64. PubMed ID: 11148007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence of human intestinal protozoa in Ibadan, Nigeria.
    Ogunba EO
    J Trop Med Hyg; 1977 Sep; 80(9):187-91. PubMed ID: 563477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Imidazoles in the treatment of infections due to parasitic protozoa "lumenals". (T. vaginalis, Giardia intestinalis, E. histolytica--general principles)].
    Grassi GG
    G Ital Chemioter; 1976; 23(1):41-6. PubMed ID: 196967
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemotherapeutic approaches to protozoa: kinetoplastida--current level of knowledge and outlook.
    Harder A; Greif G; Haberkorn A
    Parasitol Res; 2001 Sep; 87(9):778-80. PubMed ID: 11570565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antiprotozoal activity of nitazoxanide-N-methylbenzimidazole hybrids.
    Soria-Arteche O; Hernández-Campos A; Yépez-Mulia L; Trejo-Soto PJ; Hernández-Luis F; Gres-Molina J; Maldonado LA; Castillo R
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6838-41. PubMed ID: 24183540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Disinfecting effect of ammonia water on the cysts of intestinal Protozoa in the feces].
    Gordeeva LM; Chefranova IuA
    Med Parazitol (Mosk); 1977; 46(2):206-9. PubMed ID: 927349
    [No Abstract]   [Full Text] [Related]  

  • 16. Polyamine metabolism as chemotherapeutic target in protozoan parasites.
    Bacchi CJ; Yarlett N
    Mini Rev Med Chem; 2002 Dec; 2(6):553-63. PubMed ID: 12370040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding drug resistance in human intestinal protozoa.
    El-Taweel HA
    Parasitol Res; 2015 May; 114(5):1647-59. PubMed ID: 25782683
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Juárez-Saldivar A; Campillo NE; Ortiz-Perez E; Paz-Gonzalez AD; Saavedra E; Rivera G
    Med Chem; 2022; 19(1):91-98. PubMed ID: 35975866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting polyamines of parasitic protozoa in chemotherapy.
    Müller S; Coombs GH; Walter RD
    Trends Parasitol; 2001 May; 17(5):242-9. PubMed ID: 11323309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nitric oxide and anti-protozoan chemotherapy].
    Gradoni L; Ascenzi P
    Parassitologia; 2004 Jun; 46(1-2):101-3. PubMed ID: 15305696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.